or Try an Advanced Search...

    Technical Analysis for XOMAP - XOMA Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

    Grade Last Price % Change Price Change
    D 25.69 0.00% 0.00
    XOMAP closed unchanged on Thursday, November 21, 2024, on 33 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical XOMAP trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -0.70%
    Narrow Range Bar Range Contraction -0.70%
    Inside Day Range Contraction -0.70%
    Older End-of-Day Signals for XOMAP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 2 days ago
    Possible Inside Day 3 days ago
    Fell Below 50 DMA 6 days ago
    Fell Below Previous Day's Low 6 days ago
    Down 1% 6 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XOMAP Chart by TradingView
    Basic chart:

    Profile

    XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
    Classification
    Keywords: Biotechnology

    Is XOMAP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 What Makes XOMA Royalty (XOMA) a New Buy Stock
    Nov 10 XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
    Nov 9 XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Oct 22 XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
    Oct 21 Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year
    Oct 15 XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties
    Sep 23 Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
    Sep 23 XOMA Royalty Declares Quarterly Preferred Stock Dividends
    Sep 10 High Growth Tech Stocks In The United States To Watch
    Sep 4 XOMA Royalty to Present at Upcoming Investor Conferences in September
    See more XOMAP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.51
    52 Week Low 20.3265
    Average Volume 1,834
    200-Day Moving Average 24.65
    50-Day Moving Average 25.83
    20-Day Moving Average 25.99
    10-Day Moving Average 25.80
    Average True Range 0.21
    RSI (14) 44.44
    ADX 12.5
    +DI 27.21
    -DI 29.55
    Chandelier Exit (Long, 3 ATRs) 25.88
    Chandelier Exit (Short, 3 ATRs) 26.31
    Upper Bollinger Bands 26.57
    Lower Bollinger Band 25.40
    Percent B (%b) 0.25
    BandWidth 4.53
    MACD Line -0.05
    MACD Signal Line 0.00
    MACD Histogram -0.0442
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.69
    Resistance 3 (R3) 25.69 25.69 25.69
    Resistance 2 (R2) 25.69 25.69 25.69 25.69
    Resistance 1 (R1) 25.69 25.69 25.69 25.69 25.69
    Pivot Point 25.69 25.69 25.69 25.69 25.69
    Support 1 (S1) 25.69 25.69 25.69 25.69 25.69
    Support 2 (S2) 25.69 25.69 25.69 25.69
    Support 3 (S3) 25.69 25.69 25.69
    Support 4 (S4) 25.69